about
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysisSubcutaneous or intramuscular methotrexate for rheumatoid arthritisErythropoiesis-stimulating agents for anemia in rheumatoid arthritisInterventions for periodontal disease in people with rheumatoid arthritisOfatumumab for rheumatoid arthritisFebuxostat for treating chronic goutNon-biologic pharmaceutical interventions for fatigue in rheumatoid arthritisAdverse effects of biologics: a network meta-analysis and Cochrane overviewBiologic interventions for fatigue in rheumatoid arthritisImmunosuppressive Medications.Abatacept treatment for rheumatoid arthritisCTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients.Novel insights into the regulatory architecture of CD4+ T cells in rheumatoid arthritisExpression of K2P5.1 potassium channels on CD4+ T lymphocytes correlates with disease activity in rheumatoid arthritis patientsClassification of clinically useful sentences in clinical evidence resources.Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease-modifying anti-rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta-analysis (NMA).Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies.A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison.Versatile characterization of glycosylation modification in CTLA4-Ig fusion proteins by liquid chromatography-mass spectrometry.Arthritis: where are the T cells?
P2860
Q24185797-2E6206FB-E6D3-4F91-8583-7AD8A8936B9AQ24187565-2431545A-AB6A-45E9-8703-5B2D70FA2CAEQ24200775-F697089B-22B1-4F91-9EF8-778C1EBEA837Q24200961-2D3BF082-A0EA-452F-9CBA-C5CAF56BE36DQ24202719-E7C169B3-44F1-44EB-BD9E-F32D07DEE6DBQ24202984-4B971A8E-55AE-4838-B5A8-BD82F84AD88AQ24234928-EB5CEF4C-5B83-4670-9399-70E0DF8EE75BQ24235218-9139D365-909A-4D75-BA14-97E584184CF6Q26471538-D068484A-CAC5-4573-8E4A-5C11D0CE0E41Q34484801-8996912A-4EDB-4B88-9D90-E457B4A1D211Q34588972-D4AE9419-B4BC-4C8F-8F63-D8BD1AA68D3FQ34895182-D33D5250-FC4B-41EF-947E-6B83A8D4300FQ35193842-76F076B3-7840-42CC-9466-C141F1CD8A9FQ35620325-35CCBDAF-2DF2-44F0-A89B-19189D59D061Q35896001-C79CF94B-E69A-4BE8-BC49-E489BBFD1A76Q36195284-9546E98B-698A-4E19-8B1D-68AEE0AECA83Q36441438-D9E6116E-44D9-4E4A-8FAA-60D6D2C21978Q37428436-33DAF5D3-93F5-4034-8BDE-27033C9ABEA8Q38212142-76F5EB2F-F794-4538-9F21-B5B6F543C03AQ39080325-B5EE5090-20E7-4CF5-B154-F9F73BC1C9EDQ42664459-021522B7-E4DF-42E7-8F1F-364B1997202C
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Abatacept for rheumatoid arthritis
@ast
Abatacept for rheumatoid arthritis
@en
Abatacept for rheumatoid arthritis
@en-gb
Abatacept for rheumatoid arthritis
@nl
type
label
Abatacept for rheumatoid arthritis
@ast
Abatacept for rheumatoid arthritis
@en
Abatacept for rheumatoid arthritis
@en-gb
Abatacept for rheumatoid arthritis
@nl
prefLabel
Abatacept for rheumatoid arthritis
@ast
Abatacept for rheumatoid arthritis
@en
Abatacept for rheumatoid arthritis
@en-gb
Abatacept for rheumatoid arthritis
@nl
P2860
P1476
Abatacept for rheumatoid arthritis
@en
P2093
Jasvinder A Singh
Lara Maxwell
P2860
P304
P356
10.1002/14651858.CD007277.PUB2
P577
2009-10-07T00:00:00Z